Events Add an event Speakers Talks Collections
 

Speakers

Sort by
Newest
Trending
1-26 of 26
1-26 of 26
Filter
Natan Ponieman
Staff Writer at Benzinga
antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, brand, cactus, cannabidiol, cannabis conference 2021, cannabis earnings, cannabis entrepreneurs , cannabis industry, cannabis organizations, cannabis sales, canopy growth, carbonated water, constellation brands, conversation, covid-19 pandemic, cucumber, dopamine, drink, drug, drug liberalization, dvd, ginger, guava, health care, health professional, hemp, highest quality cannabis, hope, major depressive disorder, martha stewart, mdma, medical cannabis, medication, mental disorder, mentha, microdosing therapies, money, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, science, serotonin, stock prices, sugar, tetrahydrocannabinol, trading strategies, trading strategies cannabis, united states, universe, veteran, washing machine, water, wine
Sylvia Jablonski
Chief Investment Officer at Definance ETFs
antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, cannabis conference 2021, cannabis entrepreneurs , conversation, dopamine, drug, drug liberalization, health care, health professional, hemp, hope, major depressive disorder, mdma, medical cannabis, medication, mental disorder, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, serotonin, stock prices, veteran
James Lanthier
CEO at Mindset Pharma
antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, cannabis conference 2021, cannabis entrepreneurs , conversation, dopamine, drug, drug liberalization, health care, health professional, hemp, hope, major depressive disorder, mdma, medical cannabis, medication, mental disorder, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, serotonin, stock prices, veteran
Hugh Rogers
Director and CEO at XPhyto Therapeutics
antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, cannabis conference 2021, cannabis entrepreneurs , conversation, dopamine, drug, drug liberalization, health care, health professional, hemp, hope, major depressive disorder, mdma, medical cannabis, medication, mental disorder, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, serotonin, stock prices, veteran
Joseph Tucker
President & CEO at MagicMed Industries
cannabis event 2021, cannabis stocks and options, antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, biotechnology, cannabinoid, cannabis conference 2021, cannabis earnings, cannabis entrepreneurs , cannabis hedge funds, cannabis investments, cannabis investor presentation , chemical substance, chemistry, clinical trial, conversation, dopamine, drug, drug development, drug discovery, drug liberalization, enzyme, experience, first-mover advantage, hallucination, health care, health professional, hemp, highest quality cannabis, hope, investor, library, lysergic acid diethylamide, major depressive disorder, marijuana, mdma, medical cannabis, medication, mental disorder, mental health, mescaline, pharmaceutical industry, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, science, serotonin, stock prices, synthetic biology, veteran
Robert W.E. Laurie
Advisory Board Member (MAPS Canada) at Multidisciplinary Association for Psychedelic Studies (MAPS)
2019, addiction, alcoholism, alternative, attorney general, bank, biohacking, biotech, blinded experiment, business, cambridge house, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis (drug), cannabis act, capital, clinical trial, cognitive behavioral therapy, company, compass pathways, consciousness, controlled substance, coronavirus disease 2019, criminalization, dennis mckena, denver, dose (biochemistry), downtown eastside, drug, drug education, drug policy reform, education, entrepreneur, event, evidence-based medicine, extraordinary future, finance, food and drug administration, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, ibogaine, johns hopkins university, jr rahn, jurisdiction, lars wilde, legality of cannabis, lysergic acid diethylamide, major depressive disorder, market, matthew johnson, mdma, medical cannabis, medication, medicine, mental health, micro dosing, mind, mindmed, money, monopoly, motivation, motivational interviewing, multidisciplinary association for psychedelic studies, mushrooms, nevis, opioid, opium, over-the-counter drug, panel, pardon, pharmacy, physician, placebo, prescription drug, prosecutor, psilocybin, psilocybin mushroom, psychedelics, psychotherapy, public, regulation of therapeutic goods, regulatory compliance, science, silicon valley, social control, spiritual, stock, substance abuse, tech, tetrahydrocannabinol, the doors of perception, therapy, tim ferriss, traditional chinese medicine, treatment, treatment-resistant depression, united states attorney, varenicline, war on drugs, xf
Priscilla Agoncillo
Co-Founder at Original Breeders League
agriculture, anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, clinical trial, consciousness, cotton, crispr, crispr gene editing, democratic party (united states), disease, dispensary, dna, dna sequencing, dominance (genetics), dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, ethnobotany, food and drug administration, free market, gene, gene mapping, genetic engineering, genetically modified organism, genetics, genome, gerrymandering, good manufacturing practice, hair loss, hashish, health, health care, hemp, human genome, landrace, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, micropropagation, mood stabilizer, neuroplasticity, neurotransmitter, neutron, organism, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, plant tissue culture, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, science, selective serotonin reuptake inhibitor, sense, sequencing, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression, whole genome sequencing
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Thomas Howard
Co Host at Cannabis Legalization News
anti-inflammatory, antidepressant, anxiolytic, bank, bodyguard, brick and mortar, cannabidiol, cannabinoid, cannabis, cannabis (drug), credit card, crime, democratic party (united states), electronic cigarette, entourage effect, fence (criminal), financial crime, food and drug administration, gerrymandering, hsbc, jpmorgan chase, major depressive disorder, mastercard, mechanism of action, medical cannabis, medication, money laundering, neuroplasticity, neurotransmitter, paypal, pharmacology, post-traumatic stress disorder, price, psilocybin, psilocybin mushroom, psychedelic drug, sense, serotonin, suspicious activity report, swing state, tetrahydrocannabinol, underwriting, united states department of agriculture, united states postal service, visa inc.
Lola O Ohonba
Certified Medical Cannabist Specialist at WCI Health
absorption (pharmacology), alternative medicine, analgesic, anti-inflammatory, anti-predator adaptation, antidepressant, anxiolytic, appetite, bioavailability, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, democratic party (united states), doctor of pharmacy, dose (biochemistry), entourage effect, euphoria, food, food and drug administration, gerrymandering, interleukin 17, ligand (biochemistry), major depressive disorder, mechanism of action, medical cannabis, medication, neuroplasticity, neurotransmitter, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pain, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, red bull, route of administration, sense, serotonin, solvent, starbucks, sublingual administration, swing state, tetrahydrocannabinol, tetrahydrocannabivarin, topical medication
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anti-inflammatory, anticoagulant, antipsychotic, appetite, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, bronchodilator, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis industry, cannabis sativa, cannabis strain, cerebellum, certificate of analysis, chemical synapse, chronic condition, chronic fatigue syndrome, depression (mood), diabetes, dispensary, dopamine, dose (biochemistry), dravet syndrome, drug, drug enforcement administration, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, family medicine, fibromyalgia, food and drug administration, free market, gateway drug effect, good manufacturing practice, gpr55, hair loss, heartburn, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medication, medicine, mental disorder, mental health, methotrexate, morphine, national health service, nervous system, norepinephrine, nursing, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, personalized medicine, pharmaceutical industry, pharmacology, pharmacy, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, pulmonary fibrosis, randomized controlled trial, residency (medicine), rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, self-medication, serotonin, spasticities, sports medicine, sympathetic nervous system, symptom, synapse, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vagus nerve, vagus nerve stimulation, vaporizer (inhalation device), warfarin
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Kevin Carrillo
Chief Operating Officer at Cannabinoid Nation
advertising, arthritis, audience measurement, blog, brand, brand awareness, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis edible, chocolate, coca-cola, contract, dietary supplement, digital marketing, effects of cannabis, emergency department, endocannabinoid system, facebook, fibromyalgia, food, food science, game balance, google, google search, gpr55, hashtag, homeostasis, hot chocolate, hydroxychloroquine, instagram, internet, linkedin, liquid, medical school, medicine, minimum viable product, money, morphine, news, newspaper, opiate, pay to play, pepsi, placebo, product sample, psilocybin mushroom, randomized controlled trial, research, search engine optimization, shelf life, small business, social media, social media marketing, sports medicine, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, twitter, vaporizer (inhalation device), whole foods market, yeast, youtube
Ronan Levy
Founder & Executive Chairman at Field Trip Health
addiction, addiction treatments, agriculture, alkaloid, alternative medicine, anorexia nervosa, antidepressant, anxiety, aurora cannabis, benzodiazepine, cambridge house, cannabinoid, cannabis, clinical trial, conference, depressant, depression treatments, disease, drug, entrepreneurship, event, evidence-based medicine, health, health system, intellectual property, investing, ketamine, major depressive disorder, medication, mental health, mind, money, mycology, pharmaceutical industry, pharmacology, posttraumatic stress disorder, prescription drug, psilocybin, psilocybin mushroom, psychedelic therapeutics, psychedelics, psychoactive drug, psychotherapy, ptsd, public health, research, risk, social stigma, stocks, tech, university of the west indies, well-being
Dennis Mckena
Founding Partner at Lodbrok Capital LLP
2019, addiction, alcoholism, alternative, biohacking, biotech, blinded experiment, business, cambridge house, cannabis (drug), cannabis act, capital, cognitive behavioral therapy, company, compass pathways, consciousness, criminalization, dennis mckena, downtown eastside, entrepreneur, event, extraordinary future, finance, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, ibogaine, johns hopkins university, jr rahn, lars wilde, lysergic acid diethylamide, major depressive disorder, market, matthew johnson, mdma, medicine, mental health, micro dosing, mind, mindmed, money, motivation, motivational interviewing, mushrooms, opioid, panel, placebo, psilocybin, psilocybin mushroom, psychedelics, psychotherapy, public, science, silicon valley, social control, spiritual, stock, substance abuse, tech, the doors of perception, therapy, tim ferriss, treatment, treatment-resistant depression, varenicline, xf
Matthew Johnson
Associate Professor at Johns Hopkins University School of Medicine
2019, addiction, adverse drug reaction, alcoholism, alternative, anorexia nervosa, bad trip, benzodiazepine, biohacking, biotech, blinded experiment, business, cambridge house, cannabis (drug), cannabis act, capital, cognitive behavioral therapy, company, compass pathways, consciousness, controlled substances act, criminalization, dennis mckena, downtown eastside, entrepreneur, event, extraordinary future, finance, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, heroin, holistic, ibogaine, institute, johns hopkins university, jr rahn, lars wilde, lysergic acid diethylamide, major depressive disorder, market, matthew johnson, mdma, medicine, mental disorder, mental health, methadone, micro dosing, milken, mind, mindmed, money, motivation, motivational interviewing, mushrooms, n,n-dimethyltryptamine, nicotine, opioid, opioid epidemic in the united states, opioid use disorder, oxycodone/paracetamol, panel, placebo, psilocybin, psilocybin mushroom, psychedelic, psychedelics, psychiatry, psychological trauma, psychosis, psychotherapy, public, recreational drug use, schizophrenia, science, silicon valley, social control, spiritual, stock, substance abuse, substance dependence, tech, the doors of perception, therapy, tim ferris, tim ferriss, treatment, treatment-resistant depression, varenicline, xf
Lars Christian Wilde
President & Co-Founder at COMPASS Pathways
2019, addiction, alcoholism, alternative, biohacking, biotech, blinded experiment, business, cambridge house, cannabis (drug), cannabis act, capital, cognitive behavioral therapy, company, compass pathways, consciousness, criminalization, dennis mckena, downtown eastside, entrepreneur, event, extraordinary future, finance, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, ibogaine, johns hopkins university, jr rahn, lars wilde, lysergic acid diethylamide, major depressive disorder, market, matthew johnson, mdma, medicine, mental health, micro dosing, mind, mindmed, money, motivation, motivational interviewing, mushrooms, opioid, panel, placebo, psilocybin, psilocybin mushroom, psychedelics, psychotherapy, public, science, silicon valley, social control, spiritual, stock, substance abuse, tech, the doors of perception, therapy, tim ferriss, treatment, treatment-resistant depression, varenicline, xf
Nikita Alexandrov
Founder & CTO at ThinkMyco
addiction, agriculture, agtech, alzheimer's disease, anxiety, biopharmaceutical, bioprospecting, biotechnology, cambridge house, conference, dose (biochemistry), downtown eastside, drug, emotion, event, fine chemical, food, food security, fungi, fungus, hallucinogen, health, ibogaine, investing, lions mane, lysergic acid diethylamide, major depressive disorder, master of business administration, meat replacements, medication, medicinal fungi, mental health, mind, money, mushroom, mushrooms, mycology, neurodegeneration, neuroenhancement, neurogenics, nutraceuticals, obsessive–compulsive disorder, pharmaceutical industry, placebo, posttraumatic stress disorder, psilocin, psilocybin, psilocybin mushroom, psychedelic therapy, psychoactive drug, psylosibin, resource, stocks, sunstainable food, supplements, sustainability, tech
JR Rahn
Founder & Co-CEO at MindMed
2019, addiction, alcoholism, alternative, biohacking, biotech, biotechnology, blinded experiment, business, cambridge house, cannabis (drug), cannabis act, capital, cognitive behavioral therapy, company, compass pathways, conference, consciousness, criminalization, dennis mckena, downtown eastside, drug development, drug discovery, eli lilly and company, entrepreneur, event, extraordinary future, finance, food and drug administration, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, homelessness, ibogaine, investing, johns hopkins university, jr rahn, ketamine, lars wilde, lysergic acid diethylamide, magic mushrooms, major depressive disorder, market, matthew johnson, mdma, medication, medicine, mental health, mentorship, micro dosing, mind, mindmed, money, motivation, motivational interviewing, mushrooms, opioid, opioid epidemic in the united states, panel, pharmaceutical industry, phases of clinical research, placebo, psilocybin, psilocybin mushroom, psychedelic drug, psychedelics, psychotherapy, public, research, science, silicon valley, social control, spiritual, startup accelerator, startup company, stock, stocks, substance abuse, tech, the doors of perception, therapy, tim ferriss, time, treatment, treatment-resistant depression, varenicline, xf, y combinator
Charles Grob
Directior, Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center
anxiety, autism spectrum, clinical trial, disease, food and drug administration, hallucinogen, major depressive disorder, mdma, mental disorder, mental health, michael pollan, multidisciplinary association for psychedelic studies, phases of clinical research, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychiatry, psychopharmacology, psychotherapy, startups, substance dependence, technology, the doors of perception, therapy, treatment of mental disorders, venture capital
Robert Jesse
Researcher, non-profit organizer at The Johns Hopkins University
anxiety, autism spectrum, clinical trial, disease, food and drug administration, hallucinogen, major depressive disorder, mdma, mental disorder, mental health, michael pollan, multidisciplinary association for psychedelic studies, phases of clinical research, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychiatry, psychopharmacology, psychotherapy, startups, substance dependence, technology, the doors of perception, therapy, treatment of mental disorders, venture capital
Joe Green
Collaborative & Co-Founder and Chairman at Treehouse Co-Living
affordable housing, airbnb, anxiety, autism spectrum, bank, beverly hills, california, california, clinical trial, community, construction, disease, education, food and drug administration, hallucinogen, housing, lawn, lawsuit, loan, loneliness, los angeles, major depressive disorder, mdma, mental disorder, mental health, michael pollan, money, multidisciplinary association for psychedelic studies, nimby, phases of clinical research, post-traumatic stress disorder, poverty, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychiatry, psychopharmacology, psychotherapy, santa monica, california, science, scott wiener, secondary suite, startups, substance dependence, suburb, technology, the doors of perception, therapy, trade union, treatment of mental disorders, urban sprawl, venture capital, wage, walkability, watts, los angeles, zoning
Douglas Caballero
Content Strategy Advisor at C3 Presents
2018, 2019, academy awards, acl, actor, addiction, altered state of consciousness, anorexia nervosa, anxiety, attention, austin, austin, texas, blog, blu-ray, business, by, ces, charlize theron, cheetah, chung ha, cinderella (disney character), comedian, comic con, concert, conference, consciousness, creative, dallas, depersonalization, development, douglas caballero, drug, dvd, edu, ego death, electronic dance music, elizabeth warren, english language, entertainment, entrepreneur, fashion, fest, festival, film, fox news, gaming, george carlin, harvey levin, hbo, health care, humour, icon, interactive, interview, jane fonda, jeff sessions, jim carrey, joan rivers, julia roberts, k-pop, k-pop star, kanye west, kathy griffin, keynote, korea, language, leah remini, lineup, live, love, lysergic acid diethylamide, madeleine albright, major depressive disorder, mdma, media, mental health professional, middle school, minnesota, movie, music, music video, n,n-dimethyltryptamine, nancy pelosi, netflix, news, no fly list, nothing, o'shea jackson jr., obsessive–compulsive disorder, panel, paramount pictures, paramount theatre (oakland, california), performance, pop music, posttraumatic stress disorder, president of the united states, pretty woman, produce 101, psilocybin, psilocybin mushroom, psychiatry, psychological trauma, psychology, question, red carpet, richard gere, scientology, selective serotonin reuptake inhibitor, seth rogen, shit, showcase, singing, social media, south, south by southwest, south korea, southby, southwest, speaker, spotify, stand-up comedy, substance dependence, suicide, sxsw, talk, tech, technology, ted, ted nugent, television, texas, theatre, tmz, training, treatment-resistant depression, tv, united states, united states congress, united states senate, video games, waiting staff, watergate scandal, west, youtube, “south by southwest”
Tim Ferriss
Author/Entrepreneur & Angel Investor at The 4-Hour Workweek
2018, 2019, 4-hour work week, acl, addiction, adverse drug reaction, altered state of consciousness, anorexia nervosa, anxiety, austin, bad trip, benzodiazepine, bipolar disorder, business, by, ces, change your mind, comic con, compulsive behavior, concert, conference, consciousness, controlled substances act, counterculture of the 1960s, creative, depersonalization, depression, development, diagnostic and statistical manual of mental disorders, drug, edu, ego death, entertainment, entrepreneur, fest, festival, film, gaming, hallucination, hallucinogen, health care, heroin, hippocampus, institute, interactive, interview, keynote, lineup, live, lysergic acid diethylamide, major depressive disorder, mania, mdma, media, mental disorder, mental health professional, methadone, michael pollan, milken, mind–body dualism, movie, music, n,n-dimethyltryptamine, news, nicotine, obsessive–compulsive disorder, opioid, opioid epidemic in the united states, opioid use disorder, oxycodone/paracetamol, panel, performance, personality disorder, placebo, posttraumatic stress disorder, psilocybin, psilocybin mushroom, psychedelia, psychedelic, psychedelic experience, psychedelics, psychiatry, psychological trauma, psychology, psychosis, recreational drug use, red carpet, schizophrenia, science, selective serotonin reuptake inhibitor, self, serotonin, showcase, south, southby, southwest, speaker, spectrum disorder, substance abuse, substance dependence, suicide, sxsw, talk, tech, technology, ted, television, texas, the doors of perception, tim ferris, tim ferriss, training, transcendence, treatment-resistant depression, tv, varenicline, video games, west, “south by southwest”
Michael Pollan
Journalist at UC Berkeley Graduate School of Journalism
2018, 2019, 4-hour work week, acl, addiction, altered state of consciousness, anorexia nervosa, anxiety, austin, bipolar disorder, business, by, ces, change your mind, comic con, compulsive behavior, concert, conference, consciousness, counterculture of the 1960s, creative, depersonalization, depression, development, diagnostic and statistical manual of mental disorders, drug, edu, ego death, entertainment, entrepreneur, fest, festival, film, gaming, hallucination, hallucinogen, health care, hippocampus, interactive, interview, keynote, lineup, live, lysergic acid diethylamide, major depressive disorder, mania, mdma, media, mental disorder, mental health professional, michael pollan, mind–body dualism, movie, music, n,n-dimethyltryptamine, news, obsessive–compulsive disorder, panel, performance, personality disorder, placebo, posttraumatic stress disorder, psilocybin, psilocybin mushroom, psychedelia, psychedelic experience, psychedelics, psychiatry, psychological trauma, psychology, red carpet, schizophrenia, science, selective serotonin reuptake inhibitor, self, serotonin, showcase, south, southby, southwest, speaker, spectrum disorder, substance dependence, suicide, sxsw, talk, tech, technology, ted, television, texas, the doors of perception, tim ferriss, training, transcendence, treatment-resistant depression, tv, video games, west, “south by southwest”
1
1-26 of 26